onice_sleeth
New Member
The growth is attributed to the rise in incidences of diabetes, on-going patent expirations of biologic drugs such as Lantus, Humalog, and Novorapid, and the cost effectiveness of the biosimilars of insulin.
View attachment 7360
Get PDF Brochure @ http://www.micromarketmonitor.com/contact/8738589978-download_pdf_brochure.html
Other factors that drive the global the rise in the number of off-patented biologic drugs, rise in incidences of chronic disorders, growing pressure to cut healthcare expenditure, rise in aging populations, and government support and initiatives.
View attachment 7360
Get PDF Brochure @ http://www.micromarketmonitor.com/contact/8738589978-download_pdf_brochure.html
Other factors that drive the global the rise in the number of off-patented biologic drugs, rise in incidences of chronic disorders, growing pressure to cut healthcare expenditure, rise in aging populations, and government support and initiatives.